Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-09

FDA Approved: HYDROXYPROGESTERONE CAPROATE — Original Application (AuroMedics Pharma LLC)

View source ↗

Summary

FDA approved AuroMedics Pharma LLC's original application for hydroxyprogesterone caproate, a generic injectable indicated to reduce the risk of preterm birth i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxyprogesterone caproate (hydroxyprogesterone caproate)

Snippet

ORIG AP for HYDROXYPROGESTERONE CAPROATE (HYDROXYPROGESTERONE CAPROATE)